-
EP2745839
European procedure
Extract from the Register of European Patents
EP About this file: EP2745839
| EP2745839 - Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.01.2021 Database last updated on 15.06.2024 | |
| Former | The patent has been granted Status updated on 07.02.2020 | ||
| Former | Grant of patent is intended Status updated on 14.10.2019 | ||
| Former | Examination is in progress Status updated on 18.10.2017 | Most recent event Tooltip | 15.01.2021 | No opposition filed within time limit | published on 17.02.2021 [2021/07] | Applicant(s) | For all designated states Les Laboratoires Servier 35, rue de Verdun 92284 Suresnes Cedex / FR | [2014/26] | Inventor(s) | 01 /
Marsas, Stéphanie 6, allée des Chartreux 45430 Checy / FR | 02 /
Pean, Jean-Manuel 12, rue Adolphe Crespin 45000 Orleans / FR | [2014/26] | Application number, filing date | 13198744.8 | 20.12.2013 | [2014/26] | Priority number, date | FR20120003579 | 21.12.2012 Original published format: FR 1203579 | [2014/26] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | EP2745839 | Date: | 25.06.2014 | Language: | FR | [2014/26] | Type: | B1 Patent specification | No.: | EP2745839 | Date: | 11.03.2020 | Language: | FR | [2020/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.02.2014 | Classification | IPC: | A61K31/7048, A61P9/00, A61K9/00, A61K47/36, A61K9/10 | [2019/43] | CPC: |
A61K47/36 (EP,KR);
A61K9/10 (KR);
A61K31/70 (KR);
A61K31/7048 (EP);
A61K9/0095 (EP);
A61P9/00 (EP)
|
| Former IPC [2014/26] | A61K31/7048, A61K9/00, A61K47/36, A61K9/10, A23L1/30, A23L1/054 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/26] | Extension states | BA | 20.12.2013 | ME | 20.12.2013 | Title | German: | Pharmazeutische Zusammensetzung in Form einer Suspension zur Einnahme, die eine flavonoidhaltige Fraktion und Xanthangummi enthält | [2014/26] | English: | Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum | [2014/26] | French: | Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoïque et de la gomme xanthane | [2014/26] | Examination procedure | 20.12.2013 | Examination requested [2014/26] | 03.03.2014 | Despatch of a communication from the examining division (Time limit: M06) | 26.08.2014 | Reply to a communication from the examining division | 09.10.2017 | Despatch of a communication from the examining division (Time limit: M04) | 19.02.2018 | Reply to a communication from the examining division | 18.09.2019 | Cancellation of oral proceeding that was planned for 20.09.2019 | 20.09.2019 | Date of oral proceedings (cancelled) | 15.10.2019 | Communication of intention to grant the patent | 04.02.2020 | Fee for grant paid | 04.02.2020 | Fee for publishing/printing paid | 04.02.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19213282.7 / EP3669879 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.03.2014 | Opposition(s) | 14.12.2020 | No opposition filed within time limit [2021/07] | Fees paid | Renewal fee | 16.12.2015 | Renewal fee patent year 03 | 20.12.2016 | Renewal fee patent year 04 | 22.12.2017 | Renewal fee patent year 05 | 18.12.2018 | Renewal fee patent year 06 | 16.12.2019 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 11.03.2020 | [2020/48] | Documents cited: | Search | [I]FR6967M ; | [XI]FR2661610 (RHONE POULENC SANTE [FR]); | [AD]EP0711560 (ADIR [FR]); | [A]EP0835653 (MCNEIL PPC INC [US]); | [XI]FR2781156 (LAFON LABOR [FR]); | [A]WO2009083759 (WOCKHARDT RESEARCH CENTER [IN], et al); | [A]US2012070475 (ZHANG NAIJIE [US], et al); | by applicant | US5240732 | EP0711560 | US2012070475 |